Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders R. KrügerT. MüllerO. Riess Pages: 31 - 40
Altered redox state of platelet coenzyme Q10 in Parkinson's disease M. E. GötzA. GerstnerM. Gerlach Pages: 41 - 48
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations R. de la Fuente-FernándezP. K. PalA. J. Stoessl Pages: 49 - 57
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease N. GiladiT. A. TrevesA. D. Korczyn Pages: 59 - 71
Motor performance: normative data, age dependence and handedness P. H. KrausH. PrzuntekP. Klotz Pages: 73 - 85
Effects of apomorphine on visual functions in Parkinson's disease Th. BüttnerTh. MüllerW. Kuhn Pages: 87 - 94
The effects of the 21-aminosteroid U-74389G on spatial orientation in rats after a cerebral oligemic episode and iron-induced oxidative stress C. HeimW. KolasiewiczK.-H. Sontag Pages: 95 - 104
The activity of Catechol-O-Methyltransferase in parkinsonian patients with "on-off fluctuations" D. WoitallaR. KarwaszW. Kuhn Pages: 105 - 111
Tolcapone increases maximum concentration of levodopa T. MüllerD. WoitallaH. Przuntek Short Communication Pages: 113 - 119
Foreword: Parkinson's Disease: Progress in Neurodegenerative and Clinical Research W. KuhnT. MüllerM. Gerlach Pages: I - I